Jul 14, 2025, 12:32
Anticoagulation in Liver Transplant Candidates: Is Apixaban Safe?
The American Journal of Transplantation shared a post on X:
”Up to 26% of liver transplant candidates have an indication for anticoagulation whilst on the waiting list. Apixaban appears safe to use in the peri-transplant setting for low MELD patients awaiting liver transplantation.”
Title: Safety of apixaban prior to liver transplantation: A single-center Australian case-control study in a population with low scores on the model for end-stage liver disease
Authors: Katrina Tan, Zoe Yang, Elizabeth Low, Jordi Shahab, Jacqueline Balassone, Graham Starkey, Marcos Perini, Lachlan Miles, Adam Testro, Marie Sinclair, Avik Majumdar
Read the full article here.
Stay informed with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin